Abstract
Objective
Contrast-induced acute kidney injury (CI-AKI) is a common complication in patients with acute ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). The Mehran risk score was defined originally in elective PCI and may be predictive of CI-AKI. The aim of the present study was to investigate whether the Zwolle score predicts CI-AKI in patients with acute STEMI undergoing primary PCI.
Patients and methods
We analyzed the data of 314 consecutive patients (mean age 56.3 ± 11.4 years) with acute STEMI undergoing primary PCI. The study population was divided into two groups according to CI-AKI development. The Mehran score, Zwolle score, baseline characteristics, and in-hospital outcomes were recorded.
Results
Patients with CI-AKI had higher Mehran and Zwolle scores. In a receiver operating characteristic (ROC) curve analysis, high area under the curve (AUC) values were determined for Zwolle and Mehran scores (0.85 and 0.79, respectively) for CI-AKI development. A Zwolle score greater than 2 predicted CI-AKI with a sensitivity of 76.3 % and a specificity of 75.4 %. A Mehran score greater than 5 predicted CI-AKI with a sensitivity of 71.1 % and a specificity of 73.6 %.
Conclusion
Zwolle score predicts CI-AKI slightly better than the Mehran score in patients with STEMI undergoing primary PCI. This simple score can be used at the catheterization laboratory for risk stratification for the development of CI-AKI.
Zusammenfassung
Ziel
Die kontrastmittelinduzierte akute Niereninsuffizienz (CI-AKI) ist eine häufige Komplikation bei Patienten mit akutem ST-Hebungs-Infarkt (STEMI), bei denen eine primäre perkutane Koronarintervention (PCI) erfolgt. Der Mehran-Risikoscore war ursprünglich für die elektive PCI definiert und kann eine CI-AKI vorhersagen. Ziel der vorliegenden Studie war es zu untersuchen, ob sich mit dem Zwolle-Score eine CI-AKI bei Patienten mit akutem STEMI und primärer PCI vorhersagen lässt.
Patienten und Methoden
Die Daten von 314 konsekutiven Patienten (Durchschnittsalter: 56,3 ± 11,4 Jahre) mit akutem STEMI und Durchführung einer primären PCI wurden ausgewertet. Die Studienpopulation wurde je nach Auftreten einer CI-AKI oder nicht in 2 Gruppen aufgeteilt. Der Mehran-Score, der Zwolle-Score, Merkmale zu Studienbeginn und Ergebnisse während der stationären Behandlung wurden dokumentiert.
Ergebnisse
Patienten mit CI-AKI wiesen einen höheren Mehran- und Zwolle-Score auf. Bei der Receiver-operating-Characteristic(ROC)-Kurven-Analyse wurden hohe Werte für die Fläche unter der Kurve (AUC) im Zwolle- und Mehran-Score (0,85 bzw. 0,79) in Bezug auf die Entwicklung einer CI-AKI festgestellt. Ein Zwolle-Score > 2 war mit einer Sensitivität von 76,3 % und einer Spezifität von 75,4 % ein Prädiktor für eine CI-AKI. Ein Mehran-Score > 5 sagte eine CI-AKI mit einer Sensitivität von 71,1 % und einer Spezifität von 73,6 % voraus.
Schlussfolgerung
Mit dem Zwolle-Score lässt sich bei Patienten mit STEMI, bei denen eine primäre PCI erfolgt, eine CI-AKI etwas besser als mit dem Mehran-Score voraussagen. Dieser einfache Risikoscore kann zur Risikostratifizierung für das Auftreten einer CI-AKI im Katheterlabor eingesetzt werden.
Similar content being viewed by others
References
Rihal CS, Textor SC, Grill DE et al (2002) Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105:2259–2264
McCullough P (2006) Contrast induced nephropathy: experience in patients undergoing cardiovascular intervention. Catheter Cardiovasc Interv 67:335–343
Barrett BJ, Parfrey PS (2006) Clinical practice: preventing nephropathy induced by contrast medium. N Engl J Med 354:379–386
Zijlstra F, Hoorntje JCA, De Boer MJ et al (1999) Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 341:1413–1419
Marenzi G, Lauri G, Assanelli E et al (2004) Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44:1780–1785
Senoo T, Motohiro M, Kamihata H et al (2010) Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol 105:624–628
Mehran R, Aymong ED, Nikolsky E et al (2004) A simple risk score for prediction of contrast- induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 44:1393–1399
De Luca G, Suryapranata H, Hof AW van’t et al (2004) Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 109:2737–2743
Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney functionmeasured and estimated glomerular filtration rate. N Engl J Med 354:2473–2483
Schiller NB, Shah PM, Crawford M et al (1989) Recommendations for quantitation of the left ventricle by twodimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two- Dimensional Echocardiograms. J Am Soc Echocardiogr 2:358–367
Chesebro JH, Knatterud G, Roberts R et al (1987) Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 76:142–154
Mehran R, Dangas G, Abizaid AS et al (1999) Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100(18):1872–1878
Garg S, Serruys PW, Silber S et al (2011) The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial. JACC Cardiovasc Interv 4(4):432–441
Bellomo R, Ronco C, Kellum JA et al (2004) Acute Dialysis Quality Initiative workgroup: acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204–R212
Mehta RL, Kellum JA, Shah SV et al (2007) Acute kidney injury network: acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31
Cutlip DE, Windecker S, Mehran R et al (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115(17):2344–2351
Thygesen K, Alpert JS, Jaffe AS et al (2012) Joint ESC/ACCF/AHA/WHF task force for the universal definition of myocardial infarction. Third universal definition of myocardial infarction. Eur Heart J 33(20):2551–2567
Thiele H, Hildebrand L, Schirdewahn C et al (2010) Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single- Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial. J Am Coll Cardiol 55:2201–2209
Marenzi G, Assanelli E, Campodonico J et al (2010) Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission. Crit Care Med 38:438–444
Tepel M, Aspelin P, Lameire N (2006) Contrast-induced nephropathy: a clinical and evidence- based approach. Circulation 113:1799–1806
Tumlin J, Stacul F, Adam A et al (2006) CIN Consensus Working Panel:pathophysiology of contrast-induced nephropathy. Am J Cardiol 98:14–20
Uyarel H, Cam N, Ergelen M et al (2009) Contrast induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction: incidence, a simple risk score, and prognosis. Arch Med Sci 5:550–558
Wi J, Ko YG, Kim JS et al (2011) Impact of contrast- induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart 97:1753–1757
Briguori C, Airoldi F, D’Andrea D et al (2007) Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 115:1211–1217
Solomon R, Werner C, Mann D et al (1994) Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416–1420
ACT Investigators (2011) Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 124:1250–1259
Kelly AM, Dwamena B, Cronin P et al (2008) Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy: Ann Intern Med 148:284–294
Hsiao PG, Hsieh CA, Yeh CF et al (2012) Early prediction of acute kidney injury in patients with acute myocardial injury. J Crit Care 27:525
Perrin T, Descombes E, Cook S (2012) Contrast-induced nephropathy in invasive cardiology. Swiss Med Wkly 142:w13608
Sgura FA, Bertelli L, Monopoli D et al (2010) Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST- elevationmyocardial infarction. Circ Cardiovasc Interv 3:491–498
Compliance with ethical guidelines
Conflict of interest. S. Kul, H. Uyarel, O.T. Kucukdagli, M. Turfan, M.A. Vatankulu, A. Tasal, E. Erdogan, E. Asoglu, M. Sahin, T.S. Guvenc, and O. Goktekin state that there are no conflicts of interest. All studies on humans described in the present manuscript were carried out with the approval of the responsible ethics committee and in accordance with national law and the Helsinki Declaration of 1975 (in its current, revised form). Informed consent was obtained from all patients included in studies.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kul, S., Uyarel, H., Kucukdagli, O. et al. Zwolle risk score predicts contrast-induced acute kidney injury in STEMI patients undergoing PCI. Herz 40, 109–115 (2015). https://doi.org/10.1007/s00059-013-3957-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00059-013-3957-1
Keywords
- Zwolle score
- Mehran score
- Primary percutaneous coronary intervention
- Risk stratification
- ST-elevation myocardial infarction